当前位置: X-MOL首页全球导师 海外导师 › Zhang, Shu-Dong

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies Oncotarget Date: (2017) Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response Cell Death and Disease Date: (2016) SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer Oncotarget Date: (2016) PRL3-zumab, a first-in-class humanized antibody for cancer therapy JCI Insight Date: (2016) Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis Proceedings of the National Academy of Sciences Date: (2016) A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping BMC Bioinformatics Date: (2016) QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics BMC Bioinformatics Date: (2016) Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma PLOS ONE Date: (2016) Association between the expression levels of TAZ, AXL and CTGF and clinicopathological parameters in patients with colon cancer Oncology Letters Date: (2016) Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia Oncotarget Date: (2015)

推荐链接
down
wechat
bug